Pages that link to "Q40333783"

The following pages link to A potent adjuvant monophosphoryl lipid A triggers various immune responses, but not secretion of IL-1beta or activation of caspase-1. (Q40333783):

Displaying 38 items.

• Immunity to Pathogens Taught by Specialized Human Dendritic Cell Subsets (Q26777195) (← links)
• Selective activation of the p38 MAPK pathway by synthetic monophosphoryl lipid A. (Q33553810) (← links)
• Chemical synthesis and proinflammatory responses of monophosphoryl lipid A adjuvant candidates (Q33714195) (← links)
• A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside (Q33724878) (← links)
• Toll-like receptor agonists: are they good adjuvants? (Q34067537) (← links)
• Differential induction of innate immune responses by synthetic lipid a derivatives (Q34121591) (← links)
• Novel drugs targeting Toll-like receptors for antiviral therapy (Q34999938) (← links)
• Type I interferon signaling contributes to the bias that Toll-like receptor 4 exhibits for signaling mediated by the adaptor protein TRIF. (Q35695840) (← links)
• Modulating LPS signal transduction at the LPS receptor complex with synthetic Lipid A analogues (Q35737359) (← links)
• Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice (Q38636895) (← links)
• Discovery and Structure-Activity Relationships of the Neoseptins: A New Class of Toll-like Receptor-4 (TLR4) Agonists (Q35981265) (← links)
• Effects of Differences in Lipid A Structure on TLR4 Pro-Inflammatory Signaling and Inflammasome Activation. (Q36029323) (← links)
• The requirement of CD80, CD86, and ICAM-1 on the ability of adjuvant formulations to potentiate antibody responses to a Plasmodium falciparum blood-stage vaccine (Q36398927) (← links)
• Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant? (Q36421502) (← links)
• iNOS activity is critical for the clearance of Burkholderia mallei from infected RAW 264.7 murine macrophages (Q36433193) (← links)
• Burkholderia pseudomallei type III secretion system mutants exhibit delayed vacuolar escape phenotypes in RAW 264.7 murine macrophages (Q36747197) (← links)
• Adjuvant formulations possess differing efficacy in the potentiation of antibody and cell mediated responses to a human malaria vaccine under selective immune genes knockout environment (Q36766169) (← links)
• Preparation of recombinant vaccines. (Q36944222) (← links)
• Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant (Q37109519) (← links)
• The Characteristics and Function of Bacterial Lipopolysaccharides and Their Endotoxic Potential in Humans (Q38647533) (← links)
• Human TLR4 polymorphism D299G/T399I alters TLR4/MD-2 conformation and response to a weak ligand monophosphoryl lipid A. (Q39282348) (← links)
• Supplementation of whole-cell pertussis vaccines with lipopolysaccharide analogs: modification of vaccine-induced immune responses (Q40022559) (← links)
• Mechanism of Impaired NLRP3 Inflammasome Priming by Monophosphoryl Lipid A (Q40093877) (← links)
• MPLA shows attenuated pro-inflammatory properties and diminished capacity to activate mast cells in comparison with LPS. (Q41156645) (← links)
• TLR4 ligands augment antigen-specific CD8 T lymphocyte responses elicited by a viral vaccine vector (Q42131157) (← links)
• Using distinct molecular signatures of human monocytes and dendritic cells to predict adjuvant activity and pyrogenicity of TLR agonists (Q42577347) (← links)
• The cationic lipid, diC14 amidine, extends the adjuvant properties of aluminum salts through a TLR-4- and caspase-1-independent mechanism (Q42723939) (← links)
• Encryption of agonistic motifs for TLR4 into artificial antigens augmented the maturation of antigen-presenting cells (Q47114921) (← links)
• Construction of an Escherichia coli mutant producing monophosphoryl lipid A (Q50044074) (← links)
• Specific features of human monocytes activation by monophosphoryl lipid A. (Q55024241) (← links)
• MPLA inhibits release of cytotoxic mediators from human neutrophils while preserving efficient bacterial killing. (Q55073266) (← links)
• Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP Trimers In Vitro. (Q55374996) (← links)
• Incorporation of the TLR4 Agonist Monophosphoryl Lipid A Into the Bilayer of DDA/TDB Liposomes: Physico-Chemical Characterization and Induction of CD8 T-Cell Responses In Vivo (Q58827790) (← links)
• Monophosphoryl lipid A alleviated radiation-induced testicular injury through TLR4-dependent exosomes (Q90065722) (← links)
• Application of Modeling Approaches to Explore Vaccine Adjuvant Mode-of-Action (Q90401221) (← links)
• Type I IFN, Ly6C cells, and phagocytes support suppression of peritoneal carcinomatosis elicited by a TLR and CLR agonist combination (Q90436683) (← links)
• LTA1 and dmLT enterotoxin-based proteins activate antigen-presenting cells independent of PKA and despite distinct cell entry mechanisms (Q92589910) (← links)
• Inflammasome-Mediated Immunogenicity of Clinical and Experimental Vaccine Adjuvants (Q99708844) (← links)